Übersicht unserer Publikationen

  • Schott J. W., D. Hoffmann, and A. Schambach. 2015. Retrovirus-based vectors for transient and permanent cell modification. Curr Opin Pharmacol 24:135-46.
  • Suerth D. J., M. A. Morgan, S. Kloess, D. Heckl, C. Neudörfl, C. S. Falk, U. Köhl, and A. Schambach. 2015. Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors. J Mol Med doi: 10.1007/s0010901513276.
  • Schott J. W., D. Hoffmann, T. Maetzig, M. Ballmaier, T. Godinho, T. Cathomen, and A. Schambach. 2015. Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors. Cytometry 87(5):405-18.
  • Suzuki T., P. Arumugam, T. Sakagami, N. Lachmann, C. Chalk, A. Sallese, S. Abe, C. Trapnell, T. Moritz, B. Carey, P. Malik, C. Lutzko, R. Wood, and B.C. Trapnell. 2014. Pulmonary Macrophage Transplantation Therapy. Nature 514:450-54.
  • Happle C., N. Lachmann, J. Skuljec, M. Wetzke, M. Ackermann, S. Brennig, A .Mucci, A.C. Jirmo, S. Groos, A. Mirenska, C. Hennig, T. Rodt, J.P. Bankstahl, N. Schwerk, T. Moritz, and G. Hansen. 2014. Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis. Sci Transl Med 20;6(250):250ra113.
  • Kuehle J., S. Turan, T. Cantz, D. Hoffmann, J. D. Suerth, T. Maetzig, D. Zychlinski, C. Klein, D. Steinemann, C. Baum, J. Bode and A. Schambach. 2014. Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of “factor-free” induced pluripotent stem cells. Mol Ther 22:919-28.
  • Schott J.W., D. Hoffmann, T. Maetzig, F.J. Müller, D. Steinemann, D. Zychlinski, T. Cantz, C. Baum, and A. Schambach. 2014. Improved retroviral episome transfer of transcription factors enables sustained cell fate modification. Gene Ther 21(11):938-49.
  • Bobis-Wozowics S., M. Galla, J. Alzubi, J. Kuehle, C. Baum, A. Schambach, and T. Cathomen. 2014. Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery. Sci Rep 4:4656.
  • Maetzig T., J. Kuhele, A. Schwarzer, S. Turan, M. Rothe, A. Chaturvedi, M. Morgan, T.C. Ha, M. Heuser, W. Hammerschmidt, C. Baum, and A Schambach. 2014. All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinase. Biomaterials 35:4345-4356.
  • Phaltane R., R. Haemmerle, M. Rothe, U. Modlich, and M. Moritz. 2014. Efficiency and safety of O⁶-methylguanine DNA methyl-transferase (MGMT(P140K))-mediated in vivo selection in a humanized mouse model. Hum Gene Ther 25(2):144-55 2014.
  • Voelkel C., M. Galla, P.N. Dannhauser, T. Maetzig, B. Sodeik, A. Schambach, and C. Baum. 2012. Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cells. Hum Gene Ther 23:274-286.
  • Galla M., A .Schambach, C.S. Falk, T. Maetzig, J. Kuehle, K. Lange, D. Zychlinski, N .Heinz, M.H. Brugman, G. Göhring, Z. Izsvak, Z. Ivics, and C. Baum. 2011. Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Research 39:7147-7160.
  • Voelkel C., M. Galla, T. Maetzig, E. Warlich, J. Kuehle, D. Zychlinski, J. Bode, T. Cantz, A. Schambach, and C. Baum. 2010. Protein transduction from retroviral Gag precursors.  Proc Natl Acad Sci U S A. 107:7805-7819.
  • Galla M., A .Schambach, G.J. Towers, and C. Baum. 2008. Cellular restriction of retrovirus particle mediated mRNA transfer. J Virol 82:3069-3077.